Annual Gross Profit
-$119.30 K
-$164.90 K-361.62%
31 December 2022
Summary:
Navidea Biopharmaceuticals annual gross profit is currently -$119.30 thousand, with the most recent change of -$164.90 thousand (-361.62%) on 31 December 2022. During the last 3 years, it has fallen by -$237.00 thousand (-201.36%). NAVB annual gross profit is now -101.87% below its all-time high of $6.38 million, reached on 31 December 2009.NAVB Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$0.00
$0.000.00%
30 September 2023
Summary:
Navidea Biopharmaceuticals quarterly gross profit is currently $0.00, unchanged on 30 September 2023. NAVB quarterly gross profit is now -100.00% below its all-time high of $3.52 million, reached on 30 September 2015.NAVB Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
-$49.40 K
+$126.90 K+71.98%
30 September 2023
Summary:
Navidea Biopharmaceuticals TTM gross profit is currently -$49.40 thousand, with the most recent change of +$126.90 thousand (+71.98%) on 30 September 2023. NAVB TTM gross profit is now -100.51% below its all-time high of $9.60 million, reached on 30 September 2015.NAVB TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAVB Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -201.4% | -100.0% | -137.3% |
| 5 y5 years | -152.8% | -100.0% | -266.9% |
NAVB Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -201.4% | at low | -100.0% | +100.0% | -137.3% | +72.0% |
| 5 y | 5 years | -152.8% | at low | -100.0% | +100.0% | -137.3% | +72.0% |
| alltime | all time | -101.9% | +97.9% | -100.0% | +100.0% | -100.5% | +98.3% |
Navidea Biopharmaceuticals Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $0.00(0.0%) | -$49.40 K(-72.0%) |
| June 2023 | - | $0.00(-100.0%) | -$176.30 K(+3.5%) |
| Dec 2022 | -$119.30 K(-361.6%) | -$49.40 K(-61.1%) | -$170.30 K(+41.9%) |
| Sept 2022 | - | -$126.90 K(-2215.0%) | -$120.00 K(-850.0%) |
| June 2022 | - | $6000.00(+566.7%) | $16.00 K(-64.9%) |
| Dec 2021 | $45.60 K(-61.3%) | $900.00(-90.1%) | $45.60 K(-65.6%) |
| Sept 2021 | - | $9100.00(-30.5%) | $132.50 K(+1.8%) |
| June 2021 | - | $13.10 K(-41.8%) | $130.10 K(+3.6%) |
| Mar 2021 | - | $22.50 K(-74.4%) | $125.60 K(+6.7%) |
| Dec 2020 | $117.70 K(+488.5%) | $87.80 K(+1210.4%) | $117.70 K(+262.2%) |
| Sept 2020 | - | $6700.00(-22.1%) | $32.50 K(+6.6%) |
| June 2020 | - | $8600.00(-41.1%) | $30.50 K(-18.9%) |
| Mar 2020 | - | $14.60 K(+461.5%) | $37.60 K(+88.0%) |
| Dec 2019 | $20.00 K(-91.1%) | $2600.00(-44.7%) | $20.00 K(-32.4%) |
| Sept 2019 | - | $4700.00(-70.1%) | $29.60 K(+225.3%) |
| June 2019 | - | $15.70 K(-623.3%) | $9100.00(-95.9%) |
| Mar 2019 | - | -$3000.00(-124.6%) | $222.40 K(-1.5%) |
| Dec 2018 | $225.90 K(+114.1%) | $12.20 K(-177.2%) | $225.90 K(+3.1%) |
| Sept 2018 | - | -$15.80 K(-106.9%) | $219.20 K(-6.7%) |
| June 2018 | - | $229.00 K(>+9900.0%) | $235.00 K(+121.7%) |
| Mar 2018 | - | $500.00(-90.9%) | $106.00 K(+0.5%) |
| Dec 2017 | $105.50 K(-97.9%) | $5500.00(>+9900.0%) | $105.50 K(-105.1%) |
| Sept 2017 | - | $0.00(-100.0%) | -$2.06 M(+757.6%) |
| June 2017 | - | $100.00 K(>+9900.0%) | -$240.40 K(-129.1%) |
| Mar 2017 | - | $0.00(-100.0%) | $826.00 K(-53.4%) |
| Dec 2016 | $4.91 M(+63.1%) | -$2.16 M(-218.7%) | $1.77 M(-167.4%) |
| Sept 2016 | - | $1.82 M(+56.1%) | -$2.63 M(+182.4%) |
| June 2016 | - | $1.17 M(+23.2%) | -$932.00 K(-313.4%) |
| Mar 2016 | - | $947.00 K(-114.4%) | $436.80 K(-62.0%) |
| Dec 2015 | $3.01 M(-35.8%) | -$6.57 M(-286.5%) | $1.15 M(-88.0%) |
| Sept 2015 | - | $3.52 M(+38.9%) | $9.60 M(+27.7%) |
| June 2015 | - | $2.54 M(+52.8%) | $7.52 M(+29.9%) |
| Mar 2015 | - | $1.66 M(-11.9%) | $5.79 M(+23.5%) |
| Dec 2014 | $4.69 M(+487.7%) | $1.88 M(+30.6%) | $4.69 M(+47.1%) |
| Sept 2014 | - | $1.44 M(+79.3%) | $3.19 M(+54.0%) |
| June 2014 | - | $804.20 K(+44.0%) | $2.07 M(+52.7%) |
| Mar 2014 | - | $558.60 K(+45.8%) | $1.36 M(+70.0%) |
| Dec 2013 | $797.80 K(+913.7%) | $383.00 K(+17.8%) | $797.80 K(+89.2%) |
| Sept 2013 | - | $325.00 K(+261.9%) | $421.60 K(+336.4%) |
| June 2013 | - | $89.80 K(>+9900.0%) | $96.60 K(+44.6%) |
| Mar 2013 | - | $0.00(-100.0%) | $66.80 K(-15.1%) |
| Dec 2012 | $78.70 K(-86.8%) | $6800.00(>+9900.0%) | $78.70 K(+9.5%) |
| Sept 2012 | - | $0.00(-100.0%) | $71.90 K(-78.0%) |
| June 2012 | - | $60.00 K(+404.2%) | $327.50 K(+19.7%) |
| Mar 2012 | - | $11.90 K(>+9900.0%) | $273.60 K(-54.2%) |
| Dec 2011 | $597.70 K(-3.2%) | $0.00(-100.0%) | $597.70 K(-43.9%) |
| Sept 2011 | - | $255.60 K(+4090.2%) | $1.07 M(+11.0%) |
| June 2011 | - | $6100.00(-98.2%) | $959.50 K(-64.2%) |
| Mar 2011 | - | $336.00 K(-28.2%) | $2.68 M(-35.2%) |
| Dec 2010 | $617.40 K(-90.3%) | $467.80 K(+212.7%) | $4.14 M(-22.1%) |
| Sept 2010 | - | $149.60 K(-91.3%) | $5.31 M(-22.1%) |
| June 2010 | - | $1.73 M(-3.7%) | $6.82 M(+7.9%) |
| Mar 2010 | - | $1.79 M(+9.4%) | $6.32 M(-1.0%) |
| Dec 2009 | $6.38 M(+34.6%) | $1.64 M(-1.2%) | $6.38 M(+8.0%) |
| Sept 2009 | - | $1.66 M(+35.1%) | $5.91 M(+10.3%) |
| June 2009 | - | $1.23 M(-33.8%) | $5.36 M(-2.2%) |
| Mar 2009 | - | $1.86 M(+59.3%) | $5.48 M(+15.5%) |
| Dec 2008 | $4.74 M | $1.17 M(+5.2%) | $4.74 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2008 | - | $1.11 M(-17.9%) | $4.60 M(-0.9%) |
| June 2008 | - | $1.35 M(+20.1%) | $4.64 M(+12.9%) |
| Mar 2008 | - | $1.12 M(+10.1%) | $4.11 M(+4.3%) |
| Dec 2007 | $3.94 M(+15.2%) | $1.02 M(-11.2%) | $3.94 M(+1.0%) |
| Sept 2007 | - | $1.15 M(+40.5%) | $3.90 M(+18.0%) |
| June 2007 | - | $817.60 K(-14.3%) | $3.31 M(-0.5%) |
| Mar 2007 | - | $953.80 K(-2.7%) | $3.32 M(-2.8%) |
| Dec 2006 | $3.42 M(-3.5%) | $980.30 K(+76.7%) | $3.42 M(+6.2%) |
| Sept 2006 | - | $554.80 K(-33.4%) | $3.22 M(-7.1%) |
| June 2006 | - | $833.20 K(-20.7%) | $3.47 M(-6.1%) |
| Mar 2006 | - | $1.05 M(+34.5%) | $3.69 M(+4.2%) |
| Dec 2005 | $3.54 M(-1.8%) | $781.10 K(-2.5%) | $3.54 M(+5.4%) |
| Sept 2005 | - | $800.90 K(-24.3%) | $3.36 M(-7.7%) |
| June 2005 | - | $1.06 M(+17.3%) | $3.64 M(+0.5%) |
| Mar 2005 | - | $902.60 K(+50.2%) | $3.62 M(+0.5%) |
| Dec 2004 | $3.61 M(+6.6%) | $601.10 K(-44.4%) | $3.61 M(-7.2%) |
| Sept 2004 | - | $1.08 M(+4.1%) | $3.89 M(+11.3%) |
| June 2004 | - | $1.04 M(+17.4%) | $3.50 M(-2.1%) |
| Mar 2004 | - | $885.50 K(+0.3%) | $3.57 M(+5.5%) |
| Dec 2003 | $3.38 M(+31.7%) | $882.90 K(+28.3%) | $3.38 M(-7.4%) |
| Sept 2003 | - | $688.10 K(-38.2%) | $3.65 M(+12.2%) |
| June 2003 | - | $1.11 M(+59.1%) | $3.26 M(+20.5%) |
| Mar 2003 | - | $700.00 K(-39.3%) | $2.70 M(+6.2%) |
| Dec 2002 | $2.57 M(-32.4%) | $1.15 M(+296.2%) | $2.55 M(-2.5%) |
| Sept 2002 | - | $291.00 K(-48.0%) | $2.61 M(-17.0%) |
| June 2002 | - | $559.20 K(+3.1%) | $3.14 M(-8.1%) |
| Mar 2002 | - | $542.60 K(-55.4%) | $3.42 M(-3.6%) |
| Dec 2001 | $3.80 M(-25.1%) | $1.22 M(+47.4%) | $3.55 M(-12.0%) |
| Sept 2001 | - | $825.60 K(-1.3%) | $4.03 M(-6.2%) |
| June 2001 | - | $836.20 K(+24.6%) | $4.30 M(-9.1%) |
| Mar 2001 | - | $671.20 K(-60.5%) | $4.73 M(-6.8%) |
| Dec 2000 | $5.08 M(-7.5%) | $1.70 M(+55.3%) | $5.08 M(+50.3%) |
| Sept 2000 | - | $1.09 M(-13.7%) | $3.38 M(+47.9%) |
| June 2000 | - | $1.27 M(+24.5%) | $2.29 M(+3.0%) |
| Mar 2000 | - | $1.02 M(-15.2%) | $2.22 M(-58.4%) |
| Dec 1999 | $5.49 M(+24.0%) | - | - |
| June 1999 | - | $1.20 M(-7.7%) | $5.33 M(+3.9%) |
| Mar 1999 | - | $1.30 M(-20.2%) | $5.13 M(+13.2%) |
| Dec 1998 | $4.43 M(+24.7%) | $1.63 M(+35.7%) | $4.53 M(+14.6%) |
| Sept 1998 | - | $1.20 M(+20.0%) | $3.95 M(+5.3%) |
| June 1998 | - | $1.00 M(+42.9%) | $3.75 M(+2.7%) |
| Mar 1998 | - | $700.00 K(-33.5%) | $3.65 M(+2.8%) |
| Dec 1997 | $3.55 M(+610.4%) | $1.05 M(+5.2%) | $3.55 M(+42.1%) |
| Sept 1997 | - | $1.00 M(+11.1%) | $2.50 M(+56.3%) |
| June 1997 | - | $900.00 K(+50.0%) | $1.60 M(+100.0%) |
| Mar 1997 | - | $600.00 K(+500.0%) | $800.00 K(+100.0%) |
| Sept 1996 | - | $100.00 K(0.0%) | $400.00 K(+33.3%) |
| June 1996 | - | $100.00 K(>+9900.0%) | $300.00 K(0.0%) |
| Mar 1996 | - | $0.00(-100.0%) | $300.00 K(-25.0%) |
| Dec 1995 | $500.00 K(-37.5%) | $200.00 K(>+9900.0%) | $400.00 K(-50.0%) |
| Sept 1995 | - | $0.00(-100.0%) | $800.00 K(-11.1%) |
| June 1995 | - | $100.00 K(0.0%) | $900.00 K(-280.0%) |
| Mar 1995 | - | $100.00 K(-83.3%) | -$500.00 K(-77.3%) |
| Dec 1994 | $800.00 K(-113.8%) | $600.00 K(+500.0%) | -$2.20 M(-21.4%) |
| Sept 1994 | - | $100.00 K(-107.7%) | -$2.80 M(-3.4%) |
| June 1994 | - | -$1.30 M(-18.8%) | -$2.90 M(+81.3%) |
| Mar 1994 | - | -$1.60 M | -$1.60 M |
| Dec 1993 | -$5.80 M(<-9900.0%) | - | - |
| Dec 1992 | $0.00 | - | - |
FAQ
- What is Navidea Biopharmaceuticals annual gross profit?
- What is the all time high annual gross profit for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly gross profit?
- What is the all time high quarterly gross profit for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals TTM gross profit?
- What is the all time high TTM gross profit for Navidea Biopharmaceuticals?
What is Navidea Biopharmaceuticals annual gross profit?
The current annual gross profit of NAVB is -$119.30 K
What is the all time high annual gross profit for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual gross profit is $6.38 M
What is Navidea Biopharmaceuticals quarterly gross profit?
The current quarterly gross profit of NAVB is $0.00
What is the all time high quarterly gross profit for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly gross profit is $3.52 M
What is Navidea Biopharmaceuticals TTM gross profit?
The current TTM gross profit of NAVB is -$49.40 K
What is the all time high TTM gross profit for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high TTM gross profit is $9.60 M